Atlas Trials

Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes.

Clinical trial NCT00184626 · COMPLETED

Trial details

NCT number
NCT00184626
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
DiabetesDiabetes Mellitus, Type 2
Start date
2004-09-10
Primary completion
2005-10-24
Enrollment
97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.